---
title: "Iterum Therapeutics Initiates Liquidation Proceedings and Leadership Exit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280832607.md"
description: "Iterum Therapeutics Initiates Liquidation Proceedings and Leadership Exit"
datetime: "2026-03-27T17:56:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280832607.md)
  - [en](https://longbridge.com/en/news/280832607.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280832607.md)
generator: "portal-rs"
---

# Iterum Therapeutics Initiates Liquidation Proceedings and Leadership Exit

Iterum Therapeutics Initiates Liquidation Proceedings and Leadership Exit

### Related Stocks

- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ITRM.US](https://longbridge.com/en/quote/ITRM.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [ITRMF.US](https://longbridge.com/en/quote/ITRMF.US.md)

## Related News & Research

- [Oncopeptides earns EANO poster nod as PDC platform pushes into glioblastoma](https://longbridge.com/en/news/299726078.md)
- [BIONATION 2026 to Bring Canada’s Life Sciences Sector Together in Ottawa](https://longbridge.com/en/news/299236957.md)
- [Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC](https://longbridge.com/en/news/298830378.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)
- [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**